ArticleAmerican journal of translational research2021

dNLR and TILS can be used as indicators for prognosis and efficacy evaluation of neo-adjuvant chemotherapy in breast cancer.

Xiaorui Wang et al.PubMed ↗Full text ↗

No numbers read from the abstract.